Developability & Characterization
The Developability & Characterization pipeline brings together three cutting-edge programs exploring advancements in predicting, analyzing, and optimizing critical quality attributes across diverse biotherapeutic modalities. Attendees will gain insights into leveraging AI and ML tools for modeling developability parameters, applying analytical techniques to assess aggregation, stability, and immunogenicity, and tailoring characterization approaches to novel biologic drug formats. Industry experts will share experiences and discuss pressing issues through case studies, unpublished data, interactive panel discussions, and keynote presentations. The symposia and tracks showcase characterization techniques, comparing their applicability across drug classes, encouraging attendees to consider novel approaches in their programs.
January 19-20
January 20-21